Bases and foundations of the treatment of peritoneal carcinomatosis: Review article
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis. Several conditions can cause this, the most common being colon, rectum, ovary, stomach or appendix cancers, including peritone...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
UANL. Facultad de Medicina
2016
|
| Acceso en línea: | http://eprints.uanl.mx/11731/1/S1665579616300618_S300_en.pdf |
| _version_ | 1824413435769651200 |
|---|---|
| author | Castro Mesta, Julio Fernando González Guerrero, Juan Francisco Barrios Sánchez, P. Villarreal Cavazos, Gerardo |
| author_facet | Castro Mesta, Julio Fernando González Guerrero, Juan Francisco Barrios Sánchez, P. Villarreal Cavazos, Gerardo |
| author_sort | Castro Mesta, Julio Fernando |
| collection | Repositorio Institucional |
| description | Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis. Several conditions can cause this, the most common being colon, rectum, ovary, stomach or appendix
cancers, including peritoneal pseudomyxoma, among others. The abdominal cavity invasion is considered a clinical stage IV. For a long time life expectancy of this entity was very short. With the advent of meticulous techniques in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) the prognosis of patients has changed. In some conditions, these
procedures are standard treatments. CRS is a very important prognostic factor; leaving a less residual disease in the patient, the evolution will be better. The HIPEC starts immediately after the surgical event. The hyperthermia increases the cytotoxic effect of antineoplastic drugs. Numerous studies have appeared in medical literature wherein the clear improvement in survival of the affected population is demonstrated. It is essential that a multidisciplinary team participates in the decision for the best treatment option and the maximum clinical benefit of the patients. |
| format | Article |
| id | eprints-11731 |
| institution | UANL |
| language | English |
| publishDate | 2016 |
| publisher | UANL. Facultad de Medicina |
| record_format | eprints |
| spelling | eprints-117312016-11-18T23:27:05Z http://eprints.uanl.mx/11731/ Bases and foundations of the treatment of peritoneal carcinomatosis: Review article Castro Mesta, Julio Fernando González Guerrero, Juan Francisco Barrios Sánchez, P. Villarreal Cavazos, Gerardo Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis. Several conditions can cause this, the most common being colon, rectum, ovary, stomach or appendix cancers, including peritoneal pseudomyxoma, among others. The abdominal cavity invasion is considered a clinical stage IV. For a long time life expectancy of this entity was very short. With the advent of meticulous techniques in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) the prognosis of patients has changed. In some conditions, these procedures are standard treatments. CRS is a very important prognostic factor; leaving a less residual disease in the patient, the evolution will be better. The HIPEC starts immediately after the surgical event. The hyperthermia increases the cytotoxic effect of antineoplastic drugs. Numerous studies have appeared in medical literature wherein the clear improvement in survival of the affected population is demonstrated. It is essential that a multidisciplinary team participates in the decision for the best treatment option and the maximum clinical benefit of the patients. UANL. Facultad de Medicina 2016 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/11731/1/S1665579616300618_S300_en.pdf http://eprints.uanl.mx/11731/1.haspreviewThumbnailVersion/S1665579616300618_S300_en.pdf Castro Mesta, Julio Fernando y González Guerrero, Juan Francisco y Barrios Sánchez, P. y Villarreal Cavazos, Gerardo (2016) Bases and foundations of the treatment of peritoneal carcinomatosis: Review article. Medicina universitaria, 18 (71). pp. 98-104. ISSN 1665-5796 |
| spellingShingle | Castro Mesta, Julio Fernando González Guerrero, Juan Francisco Barrios Sánchez, P. Villarreal Cavazos, Gerardo Bases and foundations of the treatment of peritoneal carcinomatosis: Review article |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Bases and foundations of the treatment of peritoneal
carcinomatosis: Review article |
| title_full | Bases and foundations of the treatment of peritoneal
carcinomatosis: Review article |
| title_fullStr | Bases and foundations of the treatment of peritoneal
carcinomatosis: Review article |
| title_full_unstemmed | Bases and foundations of the treatment of peritoneal
carcinomatosis: Review article |
| title_short | Bases and foundations of the treatment of peritoneal
carcinomatosis: Review article |
| title_sort | bases and foundations of the treatment of peritoneal carcinomatosis review article |
| url | http://eprints.uanl.mx/11731/1/S1665579616300618_S300_en.pdf |
| work_keys_str_mv | AT castromestajuliofernando basesandfoundationsofthetreatmentofperitonealcarcinomatosisreviewarticle AT gonzalezguerrerojuanfrancisco basesandfoundationsofthetreatmentofperitonealcarcinomatosisreviewarticle AT barriossanchezp basesandfoundationsofthetreatmentofperitonealcarcinomatosisreviewarticle AT villarrealcavazosgerardo basesandfoundationsofthetreatmentofperitonealcarcinomatosisreviewarticle |